5
Participants
Start Date
September 1, 2016
Primary Completion Date
November 8, 2016
Study Completion Date
November 8, 2016
OctaplasLG®
"OctaplasLG is an donor plasma product pooled from approximately 1000 single donor units. It possesses unique features when compared to standard fresh frozen plasma, such as having standardized concentrations of natural pro- and anti-coagulation factors, a standardized volume as well as being pathogen free. The manufacturing method of OctaplasLG removes immune complexes and cells in several steps of microfiltration in addition to viral, bacterial and prion pathogen inactivation by immune neutralization. OctaplasLG should reduce the inflammatory hit on the endothelium, including the glycocalyx, by having standardized levels of coagulation proteins, which can give more sustainable support to the endothelial regeneration as compared to standard fresh frozen plasma."
Ringer-acetat
Crystalloid used as standard of care.
Intensive Care Unit Bispebjerg Hospital, Copenhagen
Collaborators (1)
Octapharma
INDUSTRY
Rigshospitalet, Denmark
OTHER